ArticleInorganic chemistry2024
Progress in Nonaqueous Molecular Uranium Chemistry: Where to Next?
Article in Inorganic chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- A crystalline uranium Fischer-type carbyne.Nature chemistry · 2026Article
- Reactivity Studies on the Terminal Thorium Imido Metallocene (ηInorganic chemistry · 2026Article
- Resolving the innerChemical science · 2026Article
- Transient Triamidoamine Neptunium(V)-Mono(Imido) Complexes: C-H Activations and Hydrogen Atom Transfer Driven by Effective Nuclear Charge.Journal of the American Chemical Society · 2026Article
- Unusual bonding situations in Th(iv) and U(iv)-Al(iii) pnictogen complexes.Chemical science · 2026Article
- Multinuclear uranium-nitrogen cluster formation from exploration of organouranium-ammonolysis.Communications chemistry · 2026Article
- Isolable f-element diphosphene complexes by phosphinidene group transfer and coupling at uranium.Nature communications · 2025Article
- Transuranium organometallic chemistry.Nature reviews. Chemistry · 2025Review
- Uranium-stibinidiide, -stibinidene, and -stibido multiple bonds and uranium-nitride formation from multimetallic diuranium-distibene-mediated dinitrogen cleavage.Nature communications · 2025Article
- Synthesis and Reactivity of Lewis-Base-Supported Terminal Thorium Imido Metallocene, (ηInorganic chemistry · 2025Article
- Uranium(III) and Uranium(IV)Inorganic chemistry · 2025Article
- UInorganic chemistry · 2025Article
- Influence of 1,2,4-Tri-Inorganic chemistry · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
There is long-standing interest in nonaqueous uranium chemistry because of fundamental questions about uranium's variable chemical bonding and the similarities of this pseudo-Group 6 element to its congener d-block elements molybdenum and tungsten. To provide historical context, with reference to a conference presentation slide presented around 1988 that advanced a defining collection of top targets, and the challenge, for synthetic actinide chemistry to realize in isolable complexes under normal experimental conditions, this Viewpoint surveys progress against those targets, including (i) CO and related π-acid ligand complexes, (ii) alkylidenes, carbynes, and carbidos, (iii) imidos and terminal nitrides, (iv) homoleptic polyalkyls, -alkoxides, and -aryloxides, (v) uranium-uranium bonds, and (vi) examples of topics that can be regarded as branching out in parallel from the leading targets. Having summarized advances from the past four decades, opportunities to build on that progress, and hence possible future directions for the field, are highlighted. The wealth and diversity of uranium chemistry that is described emphasizes the importance of ligand-metal complementarity in developing exciting new chemistry that builds our knowledge and understanding of elements in a relativistic regime.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.